...
首页> 外文期刊>Biochimica et biophysica acta. Reviews on cancer >CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods
【24h】

CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods

机译:CRISPR / Cas9系统作为一种创新的基因工程工具:增强序列特异性和递送方法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

While human gene therapy has gained significant attention for its therapeutic promise, CRISPR/Cas9 technology has made a breakthrough as an efficient genome editing tool by emulating prokaryotic immune defense mechanisms. Although many studies have found that CRISPR/Cas9 technology is more efficient, specific and manipulable than previous generations of gene editing tools, it can be further improved by elevating its overall efficiency in a higher frequency of genome modifications and reducing its off-target effects. Here, we review the development of CRISPR/Cas9 technology, focusing on enhancement of its sequence specificity, reduction of off-target effects and delivery systems. Moreover, we describe recent successful applications of CRISPR/Cas9 technology in laboratory and clinical studies. (C) 2015 Elsevier B.V. All rights reserved.
机译:尽管人类基因疗法因其治疗前景而备受关注,但CRISPR / Cas9技术通过模拟原核免疫防御机制,已作为一种有效的基因组编辑工具取得了突破。尽管许多研究发现CRISPR / Cas9技术比前几代基因编辑工具更有效,更具体,更可操作,但可以通过提高基因组修饰频率中的总体效率并减少脱靶效应来进一步改善它。在这里,我们回顾了CRISPR / Cas9技术的发展,重点是增强其序列特异性,减少脱靶效应和递送系统。此外,我们描述了CRISPR / Cas9技术在实验室和临床研究中的最新成功应用。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号